IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts

Journal of Neuroimmunology

Volumn 196, Issue 1-2, 2008, Pages 41-48

  Marino, Mariapaola ^a   Scuderi, Flavia ^a   Provenzano, Carlo ^a   Scheller, Jürgen ^b   Rose John, Stefan ^b   Bartoccioni, Emanuela ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Chemokines; Inflammation; Myopathies; Transsignaling

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MYOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CHEMOKINE CCL2; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MUSCLE, SKELETAL; MYOBLASTS; TIME FACTORS;

EID: 44349086922     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.02.005     Document Type: Article

References (53)

1. Bartoccioni E., Gallucci S., Scuderi F., Ricci E., Servidei S., Broccolini A., and Tonali P. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin. Exp. Immunol. 95 (1994) 166-172
2. Bartoccioni E., Michaelis D., and Hohlfeld R. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol. Lett. 42 (1994) 135-138
3. Bartoccioni E., Scuderi F., Marino M., and Provenzano C. IL-6, monocyte infiltration and parenchymal cells. Trends Immunol. 24 (2003) 299-300
4. Blau H.M., and Webster C. Isolation and characterization of human muscle cells. Proc. Natl. Acad. Sci. USA. 78 (1981) 5623-5627
5. Bower J., Vakakis N., Nicola N.A., and Austin L. Specific binding of leukemia inhibitory factor to murine myoblasts in culture. J. Cell. Physiol. 164 (1995) 93-98
6. Brivet F.G., Emilie D., and Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit. Care Med. 27 (1999) 749-755
7. Budnik A., Grewe M., Gyufko K., and Krutmann J. Analysis of the production of soluble ICAM-1 molecules by human cells. Exp. Hematol. 24 (1996) 352-359
8. Chevrel G., Page G., Granet C., Streichenberger N., Varennes A., and Miossec P. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 137 (2003) 125-133
9. Confalonieri P., Bernasconi P., Megna P., Galbiati S., Cornelio F., and Mantegazza R. Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies. J. Neuropathol. Exp. Neurol. 59 (2000) 164-169
10. De Bleecker J.L., De Paepe B., Vanwalleghem I.E., and Schröder J.M. Differential expression of chemokines in inflammatory myopathies. Neurology. 58 (2002) 1779-1785
11. De Rossi M., Bernasconi P., Baggi F., de Waal Malefyt R., and Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int. Immunol. 12 (2000) 1329-1335
12. Diamond M.S., Staunton D.E., de Fougerolles A.R., Stacker S.A., Garcia-Aguilar J., Hibbs M.L., and Springer T.A. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J. Cell. Biol. 111 (1990) 3129-3139
13. Fischer M., Goldschmitt J., Peschel C., Kallen K.J., Brakenhoff J.P.J., Wollmer A., Grötzinger J., and Rose-John S. A designer cytokine with high activity on human hematopoietic progenitor cells. Nat. Biotechnol. 15 (1997) 142-145
14. Gallucci S., Provenzano C., Mazzarelli P., Scuderi F., and Bartoccioni E. Myoblasts produce IL-6 in response to inflammatory stimuli. Int. Immunol. 10 (1998) 267-273
15. Geissmann F., Joung S., and Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
16. Goebels N., Michaelis D., Wekerle H., and Hohlfeld R. Human myoblasts as antigen-presenting cells. J. Immunol. 149 (1992) 661-667
17. Honda M., Yamamoto S., Cheng M., Yasukawa K., Suzuki H., Saito T., Osugi Y., Tokunaga T., and Kishimoto T. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148 (1992) 2175-2180
18. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., Rose-John S., Fuller G.M., Topley N., and Jones S.A. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14 (2001) 705-714
19. Illa I., Leon-Monzon M., and Dalakas M.C. Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies and natural killer cells. Ann. Neurol. 31 (1992) 46-52
20. Jones A.S. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15 (2001) 43-58
21. Jostock T., Müllberg J., Özbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., and Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268 (2001) 160-167
22. Kageyama K., Hanada K., Nigawara T., Furukawa K., Terui K., Ogura E., Motomura S., and Suda T. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells. Peptides 28 (2007) 1059-1067
23. Kaplanski G., Marin V., Montero-Julian F., Mantovani A., and Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 24 (2003) 25-29
24. Keller P., Penkowa M., Keller C., Steensberg A., Fischer C.P., Giralt M., Hidalgo J., and Pedersen B.K. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J. 19 (2005) 1181-1183
25. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23 (2005) 1-21
26. Klouche M., Bhakdi S., Hemmes M., and Rose-John S. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J. Immunol. 163 (1999) 4583-4589
27. Kumamoto T., Abe T., Ueyama H., Sugihara R., Shigenaga T., and Tsuda T. Elevated soluble intercellular adhesion molecules-1 in inflammatory myopathy. Acta Neurol. Scand. 95 (1997) 34-37
28. Lavabre-Bertrand T., Exbrayat C., Liautard J., Gaillard J.P., Baskevitch P.P., Poujol N., Duperray C., Bourquard P., and Brochier J. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies. Br. J. Hematol. 91 (1995) 871-877
29. Liprandi A., Bartoli C., Figarella-Branger D., Pellissier J.F., and Lepidi H. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol. 97 (1999) 642-648
30. Lust J.A., Donovan K.A., Kline M.P., Greipp P.R., Kyle R.A., and Maihle N.J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4 (1992) 96-100
31. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004) 677-686
32. Marino M., Scuderi F., Mazzarelli P., Mannella F., Provenzano C., and Bartoccioni E. Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts. J. Neuroimmunol. 116 (2001) 94-101
33. Marlin S.D., and Springer T.A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51 (1987) 813-819
34. Müller-Newen G., Küster A., Hemmann U., Keul R., Horsten U., Martens A., Graeve L., Wijdenes J., and Heinrich P.C. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 161 (1998) 6347-6355
35. Nagaraju K. Update on immunopathogenesis in inflammatory myopathies. Curr. Opin. Rheumathol. 13 (2001) 461-468
36. Novick D., Engelman H., Wallach D., and Rubinstein M. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170 (1989) 1409-1414
37. Oh J.W., Revel M., and Chebath J. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA. Cytokine 8 (1996) 401-409
38. Omori K., Naruishi K., Nishimura F., Yamada-Naruishi H., and Takashiba S. High glucose enhances Interleukin-6-induced vascular endothelial growth factor 165 expression via activation of gp130-mediated p44/42 MAPK-CCAAT/Enhancer binding protein signaling in gingival fibroblasts. J. Biol. Chem. 279 (2004) 6643-6649
39. Peters M., Blinn G., Solem F., Fischer M., Meyerzum Buschenfelde K.H., and Rose-John S. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. J. Immunol. 161 (1998) 3575-3581
40. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., and Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6 (1997) 315-325
41. Rose-John S., and Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300 (1994) 281-290
42. Rose-John S. Coordination of interleukin-6 biology by membrane bound and soluble receptors. Adv. Exp. Med. Biol. 495 (2001) 145-151
43. Rothlein R., Mainolfi E.A., Czajkowski M., and Marlin S.D. A form of circulating ICAM-1 in human serum. J. Immunol. 147 (1991) 3788-3793
44. Scuderi F., Mannella F., Marino M., Provenzano C., and Bartoccioni E. IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis. J. Neuroimmunol. 176 (2006) 9-15
45. Sobel R.A., Mitchell M.E., and Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136 (1990) 1309-1316
46. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
47. Staunton D.E., Marlin S.D., Stratowa C., Dustin M.L., and Springer T.A. Primary structure of intercellular adhesion molecule-1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin superfamily. Cell 52 (1988) 925-933
48. Sugiura T., Kawaguchi Y., Harigai M., Takagi K., Ohta S., Fukasawa C., Hara M., and Kamatani N. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production. J. Immunol. 164 (2000) 6593-6600
49. Taga T., and Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15 (1997) 797-819
50. van Dam M., Miillberg J., Schooltink H., Stoyan T., Brakenhofft J.P.J., Graeve L., Heinrich P.C., and Rose-John S. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J. Biol. Chem. 268 (1993) 15285-15290
51. Vollmer P., Peters M., Ehlers M., Yagame H., Matsuba T., Kondo M., Yasukawa K., Buschenfelde K.H., and Rose-John S. Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor. J. Immunol. Methods 199 (1996) 47-54
52. Weigert C., Hennige A.M., Lehmann R., Brodbeck K., Baumgartner F., Schäuble M., Häring H.U., and Schleicher E.D. Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells. J. Biol. Chem. 281 (2006) 7060-7067
53. Wiendl H., Hohlfeld R., and Kieseier B.C. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol. 26 (2005) 373-380